Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Genor Biopharma Holdings Limited ( (HK:6998) ) just unveiled an update.
Genor Biopharma Holdings Limited has announced a change in the date of its board meeting, originally scheduled for August 27, 2025, now rescheduled to August 29, 2025. This meeting is crucial for considering and approving the interim results for the first half of 2025, which could impact the company’s financial reporting and stakeholder confidence.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a biopharmaceutical company incorporated in the Cayman Islands. It operates in the healthcare industry, focusing on the development and commercialization of innovative therapeutic products.
Average Trading Volume: 1,998,758
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.57B
For a thorough assessment of 6998 stock, go to TipRanks’ Stock Analysis page.